An investigational Type 2 diabetes drug may improve glycemic control among patients that are unable to improve their blood sugar with high doses of insulin alone, according to a new study.
Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal, released Tuesday.
Walgreens and the Chicago Health System on Tuesday reminded CHS patients who were given a flu shot voucher from Walgreens to redeem the voucher by the end of the month and help increase flu vaccination rates throughout the Chicagoland area.
Walgreens on Tuesday partnered with the online platform Sharecare on the launch of a new "Answers" application, which provides access to a comprehensive and searchable drug, supplement and wellness database on Facebook.
More than 5.1 million seniors and people with disabilities on Medicare saved billions on prescription drugs, thanks to the Patient Protection and Affordable Care Act, according to Department of Health and Human Services secretary Kathleen Sebelius.
The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.
Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.
The National Community Pharmacists Association has applauded a member of its organization for participating in the organization's drug disposal program.
Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.
Many Walgreens customers are "flocking" to independent pharmacies amid the dispute between the retail pharmacy chain and pharmacy benefit manager Express Scripts, a trade group representing the PBM industry said.
Abbott is set to enroll patients into two late-stage clinical trials designed to evaluate the safety and efficacy of one of its drugs as a treatment for a difficult-to-treat chronic inflammatory skin disease.
AmLactin, an Upsher-Smith Labs brand, has announced that New York cosmetic dermatologist Doris Day will serve as an educational consultant on the brand's "Ultra Skin Performance" campaign.
The Food and Drug Administration has approved a drug that the manufacturer called the first oral contraceptive that also treats heavy menstrual bleeding.